Mario Gabelli Chroma Dex Corp. Transaction History
Gamco Investors, Inc. Et Al
- $9.3 Billion
- Q2 2025
A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Chroma Dex Corp. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 128,800 shares of CDXC stock, worth $790,832. This represents 0.01% of its overall portfolio holdings.
Number of Shares
128,800
Previous 142,800
9.8%
Holding current value
$790,832
Previous $985,000
19.8%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding CDXC
# of Institutions
168Shares Held
27.9MCall Options Held
143KPut Options Held
189K-
Vanguard Group Inc Valley Forge, PA3.92MShares$24.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.6MShares$9.84 Million0.01% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.58MShares$9.71 Million8.91% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$7.95 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...